EPISODE #181: Why most CBD oil has low bioavailability and how to change that with Dr. Sung Min Pyo, Head of Laboratory - Enabling Pharma Excipients for BASF

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

How effective is CBD oil?

On the latest episode of The Cannabis Conversation, we’re joined by Dr Sung Min Pyo - Head of Laboratory - Enabling Pharma Excipients for BASF.

A 2018 report from the World Health Organisation (WHO) estimated the bioavailability from oral consumption of CBD to be only 6% (WHO Technical Report Series 1013 - https://www.who.int/publications/i/item/9789241210225)

We explore the reasons behind this estimate and discuss the bioavailability, absorption, and solubility of CBD, alongside some potential solutions to improve its uptake in the body.

The Cannabis Conversation is sponsored by EVO NXT - the business festival for Next Generation Products (NGP). The festival offers: modern live communication with experts and big-name speakers, key note talks, summits, workshops, panel dicussions and entertainment!

More information: www.evo-nxt.com

Secure your ticket now: www.evo-nxt.com/ticketshop

About Dr. Sung Min Pyo

Dr. Sung Min Pyo holds a PhD in Pharmacy and has dedicated her career to making the world a healthier place. As an expert in the field of bioavailability, she develops novel drug delivery systems that fundamentally improve the uptake and thus the efficacy of drugs in the body. As a consultant to pharmaceutical companies and public institutions, and as a head of laboratory at BASF, she has an in-depth understanding of how to bring innovative ideas to the finished product that truly improves people's lives.

Resources

Connect with Dr. Sung Min Pyo on LinkedIn: https://www.linkedin.com/in/sung-min-pyo